Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking

NCT02130453 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

161

Enrollment

OTHER

Sponsor class

Conditions

Ischemia

Interventions

DRUG: Regadenoson

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]